- Advertisement -

Related

Mangold Takes a Bite in QQM

- Advertisement -

Stockholm (HedgeNordic) – Mangold AB has acquired a 25 percent-stake in QQM Fund Management AB, a Stockholm-based asset manager running systematic market-neutral fund QQM Equity Hedge. The total purchase price equals around SEK 3.7 million, where part of the consideration is paid in cash and the remaining consideration consists of equity in the buyer.

The cash payment amounts to approximately SEK 2.3 million. The non-cash consideration consists of newly-issued Mangold shares, corresponding to around SEK 1.4 million. The acquisition is subject to the approval of Finanspektionen and is set to make Mangold the second-largest owner of QQM Fund Management.

Mangold has previously made similar acquisitions of the same size in two other Nordic alternative asset managers, Skandinaviska Kreditfonden (SKF) and Resscapital. SKF manages several direct lending funds in the Nordics, whereas Resscapital oversees Ress Life Investments – an alternative investment fund investing in the secondary market for U.S. life insurance policies.

“We see synergies that can be created in the same way as with SKF and Resscapital, and we want to apply the same model with QQM,” said Per-Anders Tammerlöv, the CEO of Mangold, in an announcement. “QQM complements our other acquisitions very well,” added Tammerlöv, emphasizing that the asset manager’s systematic market-neutral fund focuses on a different asset class than the other acquisitions. QQM Equity Hedge employs a systematic strategy to build a well-diversified market-neutral portfolio that aims to capture the effects of fundamental and price momentum in European equity markets. The fund gained 8.1 percent in the first half of 2019 after achieving its best monthly performance on record in May.

“We are convinced that a long-term partnership with Mangold, an independent Swedish securities broker with a successful private banking business aimed at company owners, individuals and foundations, will strengthen our distribution capabilities and generate growth, Ola Björkmo, the CEO of QQM, tells HedgeNordic. “With Mangold as a partner, QQM’s systematic and uncorrelated investment strategy will be accessible to a broader group of investors,” adds Björkmo, emphasizing that the fund will be managed by the same team employing the same strategy since July of 2010.

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Eugeniu Guzun
Eugeniu Guzun
Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018. Write to Eugeniu Guzun at eugene@hedgenordic.com

Latest Articles

Systematic Multi-Strategy as a Portfolio Diversifier

By Fredrik Langenskiöld – Union Bancaire Privée: Multi-strategy funds are those that allocate to more than one alternative strategy or portfolio manager (PM) in...

Visio Allocator Delivers Record Month on AI Chip Rally

After a more muted, albeit still challenging, first quarter, multi-strategy fund Visio Allocator regained momentum starting in April and delivered its strongest month on...

Colosseum’s Difficult Stretch Continues as Co-Portfolio Manager Departs

After a volatile journey since launching in mid-2025, Colosseum Global Alpha has suffered two consecutive months of steep losses, leaving the fund down more...

CABA Offers Another Roll Down the Curve

CABA Capital has launched the fourth iteration of its Flex strategy, a three-year closed-ended AAA-yield premium strategy designed to harvest roll-down and pull-to-par effects...

Even Steven for Nordic CTAs in Mediocre May

May was another month characterized by reversals and cross-asset volatility. Strong momentum in U.S. equities contrasted with directionless moves across other markets, creating a...

Rhenman Doubles Down on Smaller Healthcare Innovators with New Fund

Many of healthcare’s most transformative breakthroughs often originate not from established industry giants, but from smaller companies developing new technologies, therapies, and treatment approaches....

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -